These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11932190)

  • 1. Chronic effects of Campylobacter infection.
    Nachamkin I
    Microbes Infect; 2002 Apr; 4(4):399-403. PubMed ID: 11932190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Campylobacter jejuni HS:23 and Guillain-Barre syndrome, Bangladesh.
    Islam Z; van Belkum A; Cody AJ; Tabor H; Jacobs BC; Talukder KA; Endtz HP
    Emerg Infect Dis; 2009 Aug; 15(8):1315-7. PubMed ID: 19751603
    [No Abstract]   [Full Text] [Related]  

  • 3. Absence of clonality of Campylobacter jejuni in serotypes other than HS:19 associated with Guillain-Barré syndrome and gastroenteritis.
    Engberg J; Nachamkin I; Fussing V; McKhann GM; Griffin JW; Piffaretti JC; Nielsen EM; Gerner-Smidt P
    J Infect Dis; 2001 Jul; 184(2):215-20. PubMed ID: 11400076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barré syndrome and gastroenteritis.
    Nachamkin I; Engberg J; Gutacker M; Meinersman RJ; Li CY; Arzate P; Teeple E; Fussing V; Ho TW; Asbury AK; Griffin JW; McKhann GM; Piffaretti JC
    J Infect Dis; 2001 Jul; 184(2):221-6. PubMed ID: 11400077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome.
    Godschalk PC; Gilbert M; Jacobs BC; Kramers T; Tio-Gillen AP; Ang CW; Van den Braak N; Li J; Verbrugh HA; Van Belkum A; Endtz HP
    Microbes Infect; 2006 Jan; 8(1):248-53. PubMed ID: 16213180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Campylobacter jejuni infection in the pathogenesis of Guillain-Barré syndrome: an update.
    Nyati KK; Nyati R
    Biomed Res Int; 2013; 2013():852195. PubMed ID: 24000328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
    Prendergast MM; Moran AP
    J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Campylobacter jejuni from patients with Guillain-Barré syndrome preferentially expresses a GD(1a)-like epitope.
    Nachamkin I; Liu J; Li M; Ung H; Moran AP; Prendergast MM; Sheikh K
    Infect Immun; 2002 Sep; 70(9):5299-303. PubMed ID: 12183587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain-Barré syndrome?
    Yuki N; Koga M; Hirata K
    Acta Neurol Scand; 2000 Aug; 102(2):132-4. PubMed ID: 10949532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbe Profile:
    Gundogdu O; Wren BW
    Microbiology (Reading); 2020 Mar; 166(3):230-232. PubMed ID: 32228803
    [No Abstract]   [Full Text] [Related]  

  • 11. Campylobacter jejuni capsular genotypes are related to Guillain-Barré syndrome.
    Heikema AP; Islam Z; Horst-Kreft D; Huizinga R; Jacobs BC; Wagenaar JA; Poly F; Guerry P; van Belkum A; Parker CT; Endtz HP
    Clin Microbiol Infect; 2015 Sep; 21(9):852.e1-9. PubMed ID: 26070960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain-Barré syndrome associated with Campylobacter jejuni infection in England, 2000-2001.
    Tam CC; Rodrigues LC; O'Brien SJ
    Clin Infect Dis; 2003 Jul; 37(2):307-10. PubMed ID: 12856224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of Campylobacter jejuni infection and the development of Guillain-Barré syndrome.
    Tsang RS
    Curr Opin Infect Dis; 2002 Jun; 15(3):221-8. PubMed ID: 12015454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barré syndrome.
    Louwen R; Horst-Kreft D; de Boer AG; van der Graaf L; de Knegt G; Hamersma M; Heikema AP; Timms AR; Jacobs BC; Wagenaar JA; Endtz HP; van der Oost J; Wells JM; Nieuwenhuis EE; van Vliet AH; Willemsen PT; van Baarlen P; van Belkum A
    Eur J Clin Microbiol Infect Dis; 2013 Feb; 32(2):207-26. PubMed ID: 22945471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study between an outbreak of Guillain-Barre syndrome in Jilin, China, and preceding Campylobacter jejuni infection.
    Zhang M; Li Q; He L; Meng F; Gu Y; Zheng M; Gong Y; Wang P; Ruan F; Zhou L; Wu J; Chen L; Fitzgerald C; Zhang J
    Foodborne Pathog Dis; 2010 Aug; 7(8):913-9. PubMed ID: 20455754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence typing confirms that Campylobacter jejuni strains associated with Guillain-Barré and Miller-Fisher syndromes are of diverse genetic lineage, serotype, and flagella type.
    Dingle KE; Van Den Braak N; Colles FM; Price LJ; Woodward DL; Rodgers FG; Endtz HP; Van Belkum A; Maiden MC
    J Clin Microbiol; 2001 Sep; 39(9):3346-9. PubMed ID: 11526174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain Barré Syndrome is induced in Non-Obese Diabetic (NOD) mice following Campylobacter jejuni infection and is exacerbated by antibiotics.
    St Charles JL; Bell JA; Gadsden BJ; Malik A; Cooke H; Van de Grift LK; Kim HY; Smith EJ; Mansfield LS
    J Autoimmun; 2017 Feb; 77():11-38. PubMed ID: 27939129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Campylobacter jejuni infection in patient with Guillain-Barré syndrome: a case report].
    Kopyta I; Wardak S
    Med Dosw Mikrobiol; 2008; 60(1):59-63. PubMed ID: 18634345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of possible cytokine induction in peripheral blood mononuclear cells by heat-stable serotypes of Campylobacter jejuni.
    Chatzipanagiotou S; Michalopoulou M; Marinou I; Boufidou F; Papavasileiou E; Trikka-Graphakos E; Kabouri E; Nicolaou C; Legakis NJ
    Clin Microbiol Infect; 2005 Jan; 11(1):63-5. PubMed ID: 15649306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
    Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
    Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.